Search by Drug Name or NDC
NDC 51754-6000-04 GLYRX-PF 0.2 mg/mL Details
GLYRX-PF 0.2 mg/mL
GLYRX-PF is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is GLYCOPYRROLATE.
Product Information
| NDC | 51754-6000 |
|---|---|
| Product ID | 51754-6000_2ae8439a-1a05-4d94-95d5-67614cbb8be3 |
| Associated GPIs | 49102030002009 |
| GCN Sequence Number | 069671 |
| GCN Sequence Number Description | glycopyrrolate/PF VIAL 0.2 MG/ML INJECTION |
| HIC3 | J2B |
| HIC3 Description | ANTICHOLINERGICS,QUATERNARY AMMONIUM |
| GCN | 32847 |
| HICL Sequence Number | 039386 |
| HICL Sequence Number Description | GLYCOPYRROLATE/PF |
| Brand/Generic | Brand |
| Proprietary Name | GLYRX-PF |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | glycopyrrolate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 0.2 |
| Active Ingredient Units | mg/mL |
| Substance Name | GLYCOPYRROLATE |
| Labeler Name | Exela Pharma Sciences, LLC |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA210997 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51754-6000-04 (51754600004)
| NDC Package Code | 51754-6000-4 |
|---|---|
| Billing NDC | 51754600004 |
| Package | 25 VIAL, SINGLE-DOSE in 1 CARTON (51754-6000-4) / 1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2018-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |